- Current report filing (8-K)
April 23 2009 - 4:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 23, 2009
CuraGen Corporation
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-23223
|
|
06-1331400
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
322 East Main Street, Branford, CT
|
|
06405
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (203) 481-1104
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02
|
Results of Operations and Financial Condition.
|
On
April 23, 2009, CuraGen Corporation, a Delaware corporation (the Company), announced its financial results for the quarter ended March 31, 2009.
The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Form 8-K (including Exhibit 99.1) shall not be deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed:
|
99.1
|
Press release issued by CuraGen Corporation on April 23, 2009.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CURAGEN CORPORATION
|
|
|
|
|
(Registrant)
|
|
|
|
|
Date: April 23, 2009
|
|
|
|
By:
|
|
/s/ Sean A. Cassidy
|
|
|
|
|
Name:
|
|
Sean A. Cassidy
|
|
|
|
|
Title:
|
|
Vice President and Chief Financial Officer
|
Curagen Corp. (MM) (NASDAQ:CRGN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Curagen Corp. (MM) (NASDAQ:CRGN)
Historical Stock Chart
From Aug 2023 to Aug 2024